Sample size determination in clinical trials with multiple endpoints

DOI10.1007/978-3-319-22005-5zbMath1321.92016OpenAlexW2318424333WikidataQ57256707 ScholiaQ57256707MaRDI QIDQ2516980

Scott R. Evans, Toshimitsu Hamasaki, Tomoyuki Sugimoto, Takashi Sozu

Publication date: 4 August 2015

Published in: SpringerBriefs in Statistics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1007/978-3-319-22005-5

zbMATH Keywords

clinical trialsmultiple endpointsevaluation of powerdetermination of sample size

Mathematics Subject Classification ID

General biostatistics (92B15) Parametric hypothesis testing (62F03) Introductory exposition (textbooks, tutorial papers, etc.) pertaining to statistics (62-01) Medical applications (general) (92C50) Statistical ranking and selection procedures (62F07) Introductory exposition (textbooks, tutorial papers, etc.) pertaining to biology (92-01)

Related Items (1)

Interim evaluation of efficacy or futility in group‐sequential trials with multiple co‐primary endpoints

This page was built for publication: Sample size determination in clinical trials with multiple endpoints